RxDoctor Payments Data

Zachary Anderson, MD

Otolaryngology · Provo, UTNPI 1659735348

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $346, 2.1 times the $163 reported in 2021. That places this record below the midpoint for otolaryngology clinicians in UT, where the typical reported total is $1,304.

$932in general payments, 2019–2025

Across 38 payments — averaging $24.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$131
  • E.r. Squibb & Sons, L.L.C.$97
  • GSK$90
  • Optinose US, Inc.$88
  • Aerin Medical Inc.$80
  • Johnson & Johnson$79
  • plus $367 from 10 others

What the payments were for

  • Food & beverage$85892%
  • Education$748%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$932 in reported general payments places this provider in the 45th percentile of 104 otolaryngology providers in Utah.

See all otolaryngology providers in Utah

Medicare billing

Part B allowed, 2024
$76,152
Medicare patients
112
Services billed
496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide43$1,106
Fluticasone Propionate45$822
Famotidine53$611
Mupirocin43$491
Omeprazole20$282
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$265
Cephalexin21$164
Methylprednisolone14$124
Ondansetron Hcl21$78
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$77
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$71

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →